Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

45.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 48.00
  • 52 Week Low: 34.00
  • Currency: UK Pounds
  • Shares Issued: 739.67m
  • Volume: 126,760
  • Market Cap: £332.85m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-23 Q1 40.47 (7.19) (1.03)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-19 124.01 (58.48) (10.72)p n/a n/a n/a n/a 0.0%
30-Sep-20 105.57 (22.57) (3.80)p n/a n/a n/a n/a 0.0%
30-Sep-21 125.06 (9.18) (1.93)p n/a n/a n/a n/a 0.0%
30-Sep-22 157.71 (21.38) (4.34)p n/a n/a n/a n/a 0.0%
30-Sep-23 169.48 (12.69) (2.41)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-24 179.90 7.70 (0.10)p n/a n/a n/a n/a 0.0%
30-Sep-25 200.70 16.25 1.06p 42.6 n/a n/a n/a 0.0%
30-Sep-26 225.13 31.33 2.89p 15.6 0.1 +174% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

BMK Market Data

Currency UK Pounds
Share Price 45.00p
Change Today -0.50p
% Change -1.10 %
52 Week High 48.00
52 Week Low 34.00
Volume 126,760
Shares Issued 739.67m
Market Cap £332.85m

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.38% below the market average33.38% below the market average33.38% below the market average33.38% below the market average33.38% below the market average
25.49% above the sector average25.49% above the sector average25.49% above the sector average25.49% above the sector average25.49% above the sector average
Price Trend
56.22% above the market average56.22% above the market average56.22% above the market average56.22% above the market average56.22% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Income Not Available
Growth
2.06% above the market average2.06% above the market average2.06% above the market average2.06% above the market average2.06% above the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
14:54 15,000 @ 45.40p
14:51 25,000 @ 45.08p
13:32 15,000 @ 43.20p
13:32 11,245 @ 43.10p
11:20 329 @ 42.20p

BMK Key Personnel

Chair Peter George
CFO Septima Maguire
CEO Trond Williksen

Top of Page